Carregant…
Antivirals for COVID-19: A critical review
No specific drugs have been approved for coronavirus disease 2019 (COVID-19) to date as the development of antivirals usually requires time. Therefore, assessment and use of currently available antiviral drugs is critical for a timely response to the current pandemic. Here, we have reviewed anti-SAR...
Autors principals: | , , , , |
---|---|
Format: | Online Article Text |
Idioma: | English |
Publicat: |
The Authors. Published by Elsevier, a division of RELX India, Pvt. Ltd on behalf of INDIACLEN.
2021
|
Matèries: | |
Accés en línia: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831805/ https://www.ncbi.nlm.nih.gov/pubmed/33521390 http://dx.doi.org/10.1016/j.cegh.2020.07.006 |